Ivone Malla | Liver Transplantation Award | Best Researcher Award

Posted on by ScienceFather

Dr. Ivone Malla, Liver Transplantation Award, Best Researcher Award

Doctorate at Hospital Universitario Austral, Argentina

Dr. Ivone Malla is a distinguished Pediatric Hepatologist from Argentina, known for her expertise in pediatric liver diseases and transplantation. She obtained her medical degree from the Universidad Nacional de La Plata School of Medicine in Buenos Aires, Argentina, in 1996, achieving top honors with an impressive average score of 8.21 out of 10.

Throughout her illustrious career, Dr. Malla has demonstrated a commitment to excellence in pediatric healthcare. She completed her residency and fellowship training in Pediatric Hepatology and Liver Transplantation at prestigious institutions both locally and abroad, including Hospital Universitario Austral and Cliniques Universitaires Saint-Luc.

Dr. Malla has made significant contributions to the field of pediatric hepatology through her clinical practice, research endeavors, and active involvement in medical societies. She has served as the Head of Pediatric Hepatology and the Pediatric Liver Transplant Unit at Hospital Universitario Austral in Pilar, Argentina, since 2010. Additionally, she holds the position of Pediatric Hepatologist at Hospital de Pediatría Garrahan in Buenos Aires.

Profile:

Education:

Qualifications and Certifications:

  • Pediatric Hepatologist, certified by the Sociedad Argentina de Pediatría, with recertification in December 2017.
  • Pediatrician, extended by the Sociedad Argentina de Pediatría with recertification in December 2011.
  • Physician, extended by the Universidad Nacional de La Plata School of Medicine, Buenos Aires, Argentina in October 1996.
  • Extended certifications in Spanish, English, and French languages.

Professional Experience:

Dr. Ivone Malla is a highly experienced pediatric hepatologist with a distinguished professional background. She currently serves as the Head of Pediatric Hepatology and the Pediatric Liver Transplant Unit at Hospital Universitario Austral in Pilar, Argentina, a position she has held since 2010. In addition, Dr. Malla has been practicing as a Pediatric Hepatologist at Hospital de Pediatría Garrahan in Buenos Aires, Argentina, since 2013. Her expertise in the field is further enriched by her fellowship training in Pediatric Gastroenterology, Hepatology, and Liver Cell Transplantation at Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, from 2007 to 2008, and her fellowship in Hepatology and Liver Transplant at Hospital Universitario Austral from 2005 to 2007. Over the years, she has been actively involved in various aspects of pediatric liver care, including outpatient clinics, liver units, and liver transplant programs. Dr. Malla’s dedication to pediatric healthcare is evident through her extensive experience in pediatric ICU, emergency care, and general pediatrics, contributing significantly to the well-being of children with liver diseases and transplantation needs.

Research Interest:

Dr. Ivone Malla’s research interests lie at the intersection of pediatric hepatology and liver transplantation, focusing on elucidating the intricacies of liver diseases in children and advancing therapeutic interventions in this specialized field. Her work encompasses a broad spectrum of topics, including pediatric liver diseases such as viral hepatitis, autoimmune hepatitis, and metabolic liver disorders. Additionally, she delves into the complexities of pediatric liver transplantation, exploring innovative techniques, outcomes assessment, and immunosuppressive strategies tailored to the unique needs of young patients. Dr. Malla is also dedicated to investigating portal hypertension, hepatocellular carcinoma, hepatobiliary imaging modalities, liver regeneration, and the immunological aspects of liver inflammation in pediatric populations. Through her research endeavors, she aims to enhance diagnostic precision, refine treatment protocols, and ultimately improve the long-term prognosis and quality of life for children with liver-related conditions.

Publication Top Noted:

Liver transplantation in hepatic epitheloid hemangioendothelioma and lung metastases: a case report

  • Authors: Selzer Soria, E.M., Campaña, A.G., Lagues, C., Fauda, M., Malla, I.
  • Published in: Archivos Argentinos de Pediatria, 2022, 120(4), pp. E187–E191
  • Abstract: This article presents a case report on liver transplantation in hepatic epithelioid hemangioendothelioma (HEHE) with lung metastases.

Propranolol treatment in Kasabach-Merritt Syndrome secondary to congenital hepatic hemangioma. Clinical case

  • Authors: Selzer Soria, E.M., Malla, I.
  • Published in: Archivos Argentinos de Pediatria, 2021, 119(1), pp. E65–E69
  • Abstract: The article discusses the use of propranolol in treating Kasabach-Merritt Syndrome secondary to congenital hepatic hemangioma through a clinical case.

Treatment of hepatitis C virus infection with new direct-acting antivirals agents in pediatrics. Case report

  • Authors: Selzer Soria, E.M., Malla, I.
  • Published in: Archivos Argentinos de Pediatria, 2021, 119(4), pp. E360–E363
  • Abstract: This article presents a case report on the treatment of hepatitis C virus infection in pediatrics using new direct-acting antiviral agents.

Long-acting release octreotide for pediatric upper gastrointestinal bleeding

  • Authors: Malla, I., López, S., Busquet, L., Cervio, G., Cuarterolo, M.
  • Published in: Revista Chilena de Pediatria, 2020, 91(2), pp. 251–254
  • Abstract: This article discusses the use of long-acting release octreotide for the treatment of pediatric upper gastrointestinal bleeding.

Gowrishankar Shanmugaraj | Biotechnology

Posted on by ScienceFather
Dr. Gowrishankar Shanmugaraj : Leading Researcher in Biotechnology

Department of Biotechnology, Science Campus, Alagappa University, India.

Congratulations, Dr. Gowrishankar Shanmugaraj, on winning the esteemed Best Researcher Award from ResearchW! Your dedication, innovative research, and scholarly contributions have truly made a significant impact in your field. Your commitment to advancing knowledge and pushing the boundaries of research is commendable. Here’s to your continued success in shaping the future of academia and making invaluable contributions to your field. Well done!

Profile: Scopus, Orcid

Education:
  • B.Sc. April 2007 Microbiology First class,Kongu College of Arts &Science, Karur – 639 006
  • M.Sc. May 2009 Microbiology First class with Distinction, Bharathidasan University, Tiruchirappalli.
  • Post M.Sc., Diploma June 2010 Advanced Diploma in Molecular Diagnostics (ADMD), First class with Distinction Department of Biotechnology, Alagappa University, Karaikudi
  • Ph.D. December 2016 Biotechnology Highly Recommended Department of Biotechnology, Alagappa University.
Experience:
  • Eight Years Experience in Teaching.
  • Thirteen Years Experience in Research.
Publications & Research Achivements:
Awards:
  • 2019 Dr. APJ Abdul Kalam Award for Young Scientist Award – 2019 presented by MARINA LABS, Reserach & Development, Chennai.
  • 2022 Promising Researcher Award – 2022 presented by Alagappa University (on Sept 5th, 2022) in recognition of the contribution made towards ‘EXCELLENCE IN RESEARCH’
  •  2023 Appreciation Award – 2023 presented by Alagappa University for Outstanding Academic and Research Excellence in acquiring the Patent & Projects during the Academic Years through 2020-21 to 2022-23
  •  2023 Best Oral Presentation Award (secured First Position) in the International Conference of Algae: FOOD, FEED, FUELS & FINE CHEMICALS – ICA-F4 23 organised by the Department of Microbiology, Bharathidasan University, Trichy during September 06th to 8th, 2023.
Publications:
  • Jothi, R., Hong, ST., Enkhtsatsral, M., Pandian, S.K. and Gowrishankar, S*., 2023. ROS mediated anticandidal efficacy of 3-Bromopyruvate prevents vulvovaginal candidiasis in mice model. PLoS One [SanFrancisco, CA : Public Library of Science] [Impact Factor: 3.752] (Accepted)
  •  Sangavi, R., Muthumanickam, S., Malligarjunan, N., Jothi, R., Boomi, P., Arivudainambi S., Raman, M., Joshi, CG., Pandian, S.K. and Gowrishankar, S*., 2023. In silico analysis unravels the promising anticariogenic efficacy of fatty acids against dental caries causing Streptococcus mutans. Journal of Biomolecular Structure & Dynamics [Taylor & Francis] [Impact Factor: 5.2] doi.org/10.1080/07391102.2023.2283155
  • Karthika, C., Malligarjunan, N., Jothi, R., Kasthuri, T., Ravi, AV., Pandian, S.K. and Gowrishankar, S*., 2023. Two novel phages PSPa and APPa inhibit planktonic, sessile and persister populations of Pseudomonas aeruginosa, and mitigate its virulence in Zebrafish model. Scientific Reports [Springer Nature] [Impact Factor: 4.6] doi.org/10.1038/s41598-023-45313-x
  • Athulya, D., Sangavi, R., Gowrishankar, S., Kumar, R., Sankaralingam, M., 2023. Deciphering the Mechanism of MRSA Targeting Copper(II) Complexes of NN2 Pincer Type Ligands. Inorganic Chemistry. [Impact factor: 4.6] doi.org/10.1021/acs.inorgchem.3c02480
Conferences:
  • Gowrishankar, S., and Pandian, S.K., (2012). Inhibitory effect of coral-associatedbacterial extracts on methicillin-resistant and susceptible Staphylococcus aureus biofilms.Clinical Microbiology and Infection 18(S3): R2416 [Wiley, Paris] (Impact Factor 14.2). DOI: 10.1111/j.1469-0691.2012.03803.x
  • Pandian, S.K., and Gowrishankar, S., (2012). Molecular characterization of methicill inresistant Staphylococcus aureus with emergence of epidemic clone of sequence type (ST)772 and novel ST 2129 in southern India. Clinical Microbiology and Infection 18(S3): R2531 [Wiley, Paris] (Impact Factor 14.2). DOI: 10.1111/j.1469-0691.2012.03803.x.
  • Gowrishankar, S., Karthika, C., and Pandian, S.K., (2012). Understanding the proteome changes in Listeria monocytogenes upon treatment with marine cyclic dipeptide-cyclo(lleucyl-l-prolyl) Journal of Proteins and Proteomics, 9 (Special issue): JPP 95 [Impact Factor: 1.0].
Book Chapters:
  • Malligarjunan, N.,ψ, Sangavi, R ψ., and Gowrishankar, S*. (2023) Antibiofilm activity of Postbiotics. In: Dharumadurai D. (eds) “Protocol Book on POSTBIOTIC”. Springer Nature Publications. ψ Equally Contributed (Under Proof-reading by the Publisher)
  • Gowrishankar, S*., Kamaladevi, A., Pandian, S.K. (2022) MALDI-TOF Analysis of Actinobacterial Peptides with Respect to MASCOT Database. In: Dharumadurai D.(eds) Methods in Actinobacteriology. Springer Protocols Handbooks. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-1728-1_36.
  • Jothi, R., Karthika, C., Kamaladevi, A., Satish, L., Pandian, S.K., and Gowrishankar, S*. CRISPR based bacterial genome editing and removal of pathogens. In: Reprogramming of the Genome: Applications of CRISPR-Cas in non-mammalian systems Volume 180, Vijaisingh (Ed.) [Elsevier Press, Cambridge MA]. Chapter 03.

May your efforts cultivate a future where the skies are not only filled with innovation but are also fortified against the challenges that technological progress may bring.

Wishing you continued success in your endeavors to secure the future of Biotechnology .

Award Manager,
Cybersecurity Awards,
International Research Awards on Cybersecurity and Cryptography,
cybersecurity@researchw.com